Publisher
Springer Science and Business Media LLC
Subject
Hematology,General Medicine
Reference44 articles.
1. Ansell J, Hirsh J, Hylek E et al (2008) The pharmacology and management of the vitamin K antagonists: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th edition). Chest 133:160S–198S
2. Connolly SJ, Ezekowitz MD, Yusuk S, et al. (2009) Dabigatran versus warfarin in patients with atrial fibrillation (RE-LY). N Engl J Med 361. 10.1056/NEJMoa0905561
3. Schulman S, Kearon C, Kakkar AK, et al. (2009) Dabigatran versus warfarin in the treatment of acute venous thromboembolism (RE-COVER). N Engl J Med 361. 10.1056/NEJMoa0906598
4. Eriksson BI, Dahl OE, Rosencher N et al (2007) Dabigatran etexilate versus enoxaparin for prevention of venous thromboembolism after total hip replacement: a randomised, double-blind, non-inferiority trial (RE-NOVATE). Lancet 370:949–956
5. Turpie AGG, Lassen MR, Davidson BL et al (2009) Rivaroxaban versus enoxaparin for thromboprophylaxis after total knee arthroplasty (RECORD4): a randomised trial. Lancet 373:1673–1680
Cited by
67 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献